2nd Department of Cardiology and Angiology, Silesian Center for Heart Disease, Zabrze, Poland.
3rd Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Silesian Center for Heart Disease, Zabrze, Poland.
Dis Markers. 2017;2017:8165219. doi: 10.1155/2017/8165219. Epub 2017 Jul 24.
The specific association between genetic variation and in-stent restenosis is still only partly understood. The aim of this study is to analyze the relationship between functional polymorphisms in the genes encoding vascular endothelial growth factor A (VEGF-A; rs699947) and transforming growth factor beta 1 (TGF-1; rs1800470) and target lesion revascularization (TLR) risk.
A total of 676 patients (805 lesions) with stable coronary artery disease (SCAD) who received elective percutaneous coronary intervention (PCI) with at least one bare-metal stent implantation were included. The primary study endpoint was TLR at a 4-year follow-up.
The TLR rate was higher in patients with the A/A genotype (15.4%) than in patients with the A/C (7.9%) and C/C (8.9%) genotypes ( = 0.009). The A/A genotype, after adjustment for clinical and procedural covariates, remained significantly and independently associated with the TLR (hazard ratio-2.09 [95% confidence interval 1.32-3.33, = 0.0017]). However, we found no association between TLR and the genotype.
The A/A genotype is significantly and independently associated with TLR risk in Polish SCAD patients who received elective PCI with bare-metal stent implantation.
遗传变异与支架内再狭窄之间的具体关联仍不完全清楚。本研究旨在分析血管内皮生长因子 A(VEGF-A;rs699947)和转化生长因子-β1(TGF-β1;rs1800470)基因编码的功能多态性与靶病变血运重建(TLR)风险之间的关系。
共纳入 676 例(805 处病变)接受择期经皮冠状动脉介入治疗(PCI)且至少植入 1 枚裸金属支架的稳定性冠心病(SCAD)患者。主要研究终点为 4 年随访时的 TLR。
与 A/C(7.9%)和 C/C(8.9%)基因型患者相比,A/A 基因型患者的 TLR 发生率更高(15.4%)( = 0.009)。在调整了临床和手术相关混杂因素后,A/A 基因型仍与 TLR 显著相关(风险比-2.09 [95%置信区间 1.32-3.33, = 0.0017])。然而,我们没有发现 TLR 与基因型之间存在关联。
在接受择期 PCI 联合裸金属支架植入术的波兰 SCAD 患者中,A/A 基因型与 TLR 风险显著相关且独立相关。